Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a tiny skin port replace daily insulin shots for pregnant moms?

NCT ID NCT07165327

First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 33 times

Summary

This study compares using an injection port versus standard single-use needles for giving insulin to pregnant women with diabetes. The port is placed on the skin and changed every few days, allowing insulin to be delivered without repeated needle sticks. Researchers want to see if this approach helps women stick to their insulin schedule and feel more satisfied with their treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas at Austin, Dell Medical School

    Austin, Texas, 78705, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Injection port device (i-port) for insulin administration

What this could lead to

If it works, this could offer a less painful and more convenient way for pregnant women with diabetes to take their insulin, potentially improving blood sugar control and treatment satisfaction.

What could go wrong

This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The port may cause skin irritation or not significantly improve adherence compared to standard needles.

Conditions

The condition(s) this trial relates to.

gestational diabetes Insulin Resistance Patient Satisfaction type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.